These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 19784800)

  • 1. A novel indicator of widespread endothelial damage and ischemia in diabetic patients: ischemia-modified albumin.
    Ukinc K; Eminagaoglu S; Ersoz HO; Erem C; Karahan C; Hacihasanoglu AB; Kocak M
    Endocrine; 2009 Dec; 36(3):425-32. PubMed ID: 19784800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ischemia-modified albumin level in type 2 diabetes mellitus - Preliminary report.
    Piwowar A; Knapik-Kordecka M; Warwas M
    Dis Markers; 2008; 24(6):311-7. PubMed ID: 18688079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcapillary escape rate of albumin in type II diabetic patients. The relationship with microalbuminuria and hypertension.
    Nannipieri M; Penno G; Rizzo L; Pucci L; Bandinelli S; Mattei P; Taddei S; Salvetti A; Navalesi R
    Diabetes Care; 1997 Jun; 20(6):1019-26. PubMed ID: 9167118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the Relationship Between Microalbuminuria and Urine Ischemia-Modified Albumin Levels in Patients with Diabetic Nephropathy.
    Bilgi M; Keser A; Katlandur H; Sahin E; Kalkan AO; Yildiz M; Kiyici A; Keles M
    J Clin Lab Anal; 2017 May; 31(3):. PubMed ID: 27696561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Endocan, Ischemia-Modified Albumin, and hsCRP Levels With Endothelial Dysfunction in Type 2 Diabetes Mellitus.
    Balamir I; Ates I; Topcuoglu C; Turhan T
    Angiology; 2018 Aug; 69(7):609-616. PubMed ID: 29172652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin resistance and endothelial dysfunction in type 2 diabetes patients with or without microalbuminuria.
    Yu Y; Suo L; Yu H; Wang C; Tang H
    Diabetes Res Clin Pract; 2004 Aug; 65(2):95-104. PubMed ID: 15223221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Type 2 diabetes mellitus without vascular complications and ischemia modified albumin.
    Dahiya K; Aggarwal K; Seth S; Singh V; Sharma TK
    Clin Lab; 2010; 56(5-6):187-90. PubMed ID: 20575465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Skin microvascular endothelial dysfunction is associated with type 2 diabetes independently of microalbuminuria and arterial stiffness.
    Jonasson H; Bergstrand S; Nystrom FH; Länne T; Östgren CJ; Bjarnegård N; Fredriksson I; Larsson M; Strömberg T
    Diab Vasc Dis Res; 2017 Jul; 14(4):363-371. PubMed ID: 28482676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship between diabetic retinopathy and serum levels of ischemia-modified albumin and malondialdehyde.
    Turk A; Nuhoglu I; Mentese A; Karahan SC; Erdol H; Erem C
    Retina; 2011 Mar; 31(3):602-8. PubMed ID: 21273947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Ischemia Modified Albumin Serum Levels as an Oxidative Stress Marker in Children with Diabetic Ketoacidosis.
    Yazıcı MU; Ayar G; Savas-Erdeve S; Azapağası E; Neşelioğlu S; Erel Ö; Çetinkaya S
    Comb Chem High Throughput Screen; 2019; 22(8):577-581. PubMed ID: 31595845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Novel Systemic Indicator of Periodontal Tissue Damage: Ischemia Modified Albumin.
    Tayman MA; Önder C; Kurgan Ş; Serdar MA; Günhan M
    Comb Chem High Throughput Screen; 2018; 21(8):544-549. PubMed ID: 30338733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum ischemic modified albumin levels might not be a marker of oxidative stress in patients with hypothyroidism.
    Ersoy K; Anaforoğlu İ; Algün E
    Endocrine; 2013 Apr; 43(2):430-3. PubMed ID: 23001626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ischemia modified albumin: an oxidative stress marker in β-thalassemia major.
    Awadallah SM; Atoum MF; Nimer NA; Saleh SA
    Clin Chim Acta; 2012 May; 413(9-10):907-10. PubMed ID: 22336636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations of FPG, A1C and disease duration with protein markers of oxidative damage and antioxidative defense in type 2 diabetes and diabetic retinopathy.
    Reddy VS; Agrawal P; Sethi S; Gupta N; Garg R; Madaan H; Kumar V
    Eye (Lond); 2015 Dec; 29(12):1585-93. PubMed ID: 26381098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of ultrasensitive CRP and microalbuminuria as cardiovascular risk markers in type 2 diabetic moroccan patients.
    El Boukhrissi F; Benbella I; Ouleghzal H; Safi S; Bamou Y; Balouch L
    Tunis Med; 2017 Novembre; 95(11):982-987. PubMed ID: 29877557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ischemia Modified Albumin (IMA) - A Marker of Glycaemic Control and Vascular Complications in Type 2 Diabetes Mellitus.
    Chawla R; Loomba R; Guru D; Loomba V
    J Clin Diagn Res; 2016 Mar; 10(3):BC13-6. PubMed ID: 27134857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between ischemia modified albumin, inflammation and hyperglycemia in type 2 diabetes mellitus.
    Kaefer M; Piva SJ; De Carvalho JA; Da Silva DB; Becker AM; Coelho AC; Duarte MM; Moresco RN
    Clin Biochem; 2010 Mar; 43(4-5):450-4. PubMed ID: 19968982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microvascular and macrovascular reactivity is reduced in subjects at risk for type 2 diabetes.
    Caballero AE; Arora S; Saouaf R; Lim SC; Smakowski P; Park JY; King GL; LoGerfo FW; Horton ES; Veves A
    Diabetes; 1999 Sep; 48(9):1856-62. PubMed ID: 10480619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationships among microalbuminuria, insulin resistance and renal-cardiac complications in insulin dependent and non insulin dependent diabetes.
    Nosadini R; Brocco E
    Exp Clin Endocrinol Diabetes; 1997; 105 Suppl 2():1-7. PubMed ID: 9288531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased serum levels of ischemia-modified albumin and C-reactive protein in type 1 diabetes patients with ketoacidosis.
    Ma SG; Jin Y; Xu W; Hu W; Bai F; Wu XJ
    Endocrine; 2012 Dec; 42(3):570-6. PubMed ID: 22437883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.